Lisata Therapeutics Inc. Cash Flow-to-Debt Ratio
Lisata Therapeutics Inc. cash flow-to-debt ratio. Lisata Therapeutics Inc. (LSTA) has a Cash Flow-to-Debt Ratio of -0.87x as of June 2026, meaning its operating cash flow of $-2.65 Million could theoretically repay -1% of its total liabilities ($3.04 Million) in one year. Check LSTA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Lisata Therapeutics Inc. (1993–2025)
Cash flow-to-debt ratio of Lisata Therapeutics Inc. from 1993 to 2025. Historical debt coverage capacity for Lisata Therapeutics Inc. across 32 annual periods. Check how aggressively does Lisata Therapeutics Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Lisata Therapeutics Inc. Cash Flow-to-Debt Ratio by Year (1993–2025)
Lisata Therapeutics Inc. cash flow-to-debt ratio by year from 1993 to 2025. Year-by-year debt coverage analysis for Lisata Therapeutics Inc.. For the full cash flow conversion analysis, see LSTA operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.07x | $-15.95 Million | $3.14 Million | ▼ -49.0% |
| 2024 | -3.40x | $-19.36 Million | $5.68 Million | ▼ -15.6% |
| 2023 | -2.95x | $-20.03 Million | $6.80 Million | ▲ +6.6% |
| 2022 | -3.15x | $-21.17 Million | $6.71 Million | ▲ +29.0% |
| 2021 | -4.44x | $-22.25 Million | $5.01 Million | ▼ -89.3% |
| 2020 | -2.35x | $-8.82 Million | $3.76 Million | ▲ +18.0% |
| 2019 | -2.86x | $-18.88 Million | $6.60 Million | ▼ -2.0% |
| 2018 | -2.80x | $-19.99 Million | $7.13 Million | ▼ -77.2% |
| 2017 | -1.58x | $-20.88 Million | $13.19 Million | ▼ -219.5% |
| 2016 | -0.50x | $-23.67 Million | $47.77 Million | ▲ +57.2% |
| 2015 | -1.16x | $-39.26 Million | $33.92 Million | ▼ -68.3% |
| 2014 | -0.69x | $-46.90 Million | $68.20 Million | ▲ +29.5% |
| 2013 | -0.98x | $-27.10 Million | $27.79 Million | ▼ -52.0% |
| 2012 | -0.64x | $-13.85 Million | $21.59 Million | ▼ -130.6% |
| 2011 | -0.28x | $-20.93 Million | $75.20 Million | ▼ -85.6% |
| 2010 | -0.15x | $-8.48 Million | $56.54 Million | ▲ +19.5% |
| 2009 | -0.19x | $-8.65 Million | $46.45 Million | ▲ +96.2% |
| 2008 | -4.92x | $-4.73 Million | $961.14K | ▲ +63.2% |
| 2007 | -13.36x | $-6.13 Million | $458.95K | ▼ -231.5% |
| 2006 | -4.03x | $-3.64 Million | $902.87K | ▼ -1089.0% |
| 2005 | -0.34x | $-834.00K | $2.46 Million | ▲ +52.8% |
| 2004 | -0.72x | $-1.46 Million | $2.03 Million | ▼ -27.6% |
| 2003 | -0.56x | $-1.02 Million | $1.81 Million | ▼ -212.4% |
| 2002 | 0.50x | $1.01 Million | $2.01 Million | ▲ +296.0% |
| 2001 | -0.26x | $-373.84K | $1.46 Million | ▲ +80.8% |
| 2000 | -1.33x | $-1.98 Million | $1.49 Million | ▼ -355.6% |
| 1999 | -0.29x | $-364.12K | $1.25 Million | ▼ -31.3% |
| 1998 | -0.22x | $-269.60K | $1.21 Million | ▲ +51.3% |
| 1996 | -0.46x | $-304.27K | $666.62K | ▲ +75.2% |
| 1995 | -1.84x | $-838.44K | $455.31K | ▼ -2684.2% |
| 1994 | -0.07x | $-840.00K | $12.70 Million | ▼ -208.4% |
| 1993 | 0.06x | $470.00K | $7.70 Million | — |